CUSIP: 35655L107
What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 35655L107:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q1 | 0 | $0 | -$9,326,984 | 0 | |
| 2023 Q4 | 1,466,507 | $9,326,984 | $6.36 | 1 | |
| 2023 Q3 | 1,466,507 | $6,217,990 | -$4 | $4.24 | 1 |
| 2023 Q2 | 1,466,508 | $3,783,591 | -$59,742,505 | $2.58 | 1 |
| 2023 Q1 | 36,854,489 | $16,904,846 | -$555,491 | $0.46 | 15 |
| 2022 Q4 | 38,057,795 | $18,192,005 | +$49,718 | $0.48 | 16 |
| 2022 Q3 | 37,948,285 | $26,372,000 | -$57,772 | $0.70 | 13 |
| 2022 Q2 | 37,990,866 | $33,216,000 | +$1,800,193 | $0.87 | 16 |
| 2022 Q1 | 13,893,953 | $15,492,000 | +$1,816,294 | $1.12 | 16 |
| 2021 Q4 | 13,200,510 | $25,974,000 | -$1,879,119 | $1.98 | 18 |
| 2021 Q3 | 10,610,967 | $36,109,000 | -$7,787,454 | $3.41 | 19 |
| 2021 Q2 | 11,303,478 | $91,623,000 | -$4,785,853 | $8.15 | 16 |
| 2021 Q1 | 11,770,309 | $144,027,000 | -$1,976,258 | $12.30 | 19 |
| 2020 Q4 | 11,923,678 | $216,605,000 | +$28,323,349 | $18.26 | 20 |
| 2020 Q3 | 9,975,309 | $154,754,000 | +$154,754,000 | $15.61 | 22 |